Gayle(Pageau)PouliotMD

Pediatric Hematologic Oncology

Pediatric Hematology at Boston Childrens Hospital Early Oncology Clinical Development, AstraZeneca

Dr. Pouliot is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2012 - 2015
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2009 - 2012
University of Massachusetts Medical SchoolClass of 2009

PubMed

95 citations
The disappearing Barr body in breast and ovarian cancers
Gayle Jeannette Pageau, Lisa L. Hall, Shridar Ganesan, David M. Livingston, Jeanne B. Lawrence
Nature Reviews. Cancer. 2007-08-01
50 citations
MEF2C Phosphorylation Is Required for Chemotherapy Resistance in Acute Myeloid Leukemia
Fiona C. Brown, Eric Still, Richard Koche, Christina Y. Yim, Sumiko Takao
Cancer Discovery. 2018-04-01
52 citations
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response.
Ben Sidders, Pei Zhang, Kelly Goodwin, Greg O'Connor, Deanna L. Russell
Clinical Cancer Research. 2020-01-01

Journal Articles

BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
Pageau, G.J., Hall, L.L., Lawrence, J.B., J, Cell Biochem, 3/1/2007